logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9815797 B1

PDFFull Text
Expired
Date of Patent:
Nov. 14, 2017

Filed:

Dec. 08, 2014

Fused bicyclic heteroaromatic derivatives as modulators of tnf activity

Applicant:

Ucb Biopharma Sprl, Brussels, BE;

Inventors:

Rikki Peter Alexander, Slough, GB;

Gregory Foulkes, Abingdon, GB;

Martin Clive Hutchings, Slough, GB;

Victoria Elizabeth Jackson, Slough, GB;

Boris Kroeplien, Slough, GB;

James Thomas Reuberson, Slough, GB;

Sarah Margaret Rook, Abingdon, GB;

Zhaoning Zhu, Slough, GB;

Assignee:

UCB Biopharma SPRL, Brussels, BE;

Attorney:

McDonnell Boehnen Hulbert & Berghoff LLP

Primary Examiner:

Savitha Rao

Int. Cl.
CPC ...
C07D 239/74 (2006.01); A61K 31/47 (2006.01); A61K 31/472 (2006.01); A61K 31/498 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); C07D 215/14 (2006.01); C07D 237/28 (2006.01); A61K 31/502 (2006.01); C07D 215/06 (2006.01); C07D 237/32 (2006.01); C07D 241/44 (2006.01); A61K 45/06 (2006.01); C07D 217/16 (2006.01); C07D 241/42 (2006.01); C07D 403/04 (2006.01);
U.S. Cl.
CPC ...
C07D 239/74 (2013.01); A61K 31/47 (2013.01); A61K 31/472 (2013.01); A61K 31/498 (2013.01); A61K 31/502 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 45/06 (2013.01); C07D 215/06 (2013.01); C07D 215/14 (2013.01); C07D 217/16 (2013.01); C07D 237/28 (2013.01); C07D 237/32 (2013.01); C07D 241/42 (2013.01); C07D 241/44 (2013.01); C07D 403/04 (2013.01);
Abstract

A series of substituted heteroaromatic compounds containing two fused six-membered rings, tivity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.

Find Patent Forward Citations

Alexander, Rikki. (2017). Fused bicyclic heteroaromatic derivatives as modulators of tnf activity (U.S. Patent No. 9815797). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/9815797

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…